Drug General Information
Drug ID	D0W7UN
Former ID	DNCL003147
Drug Name	BI-409306
Indication	Psychiatric disorder [ICD9: 290-319; ICD10:F01-F99]		Phase 2	[524914]
Company	Boehringer Ingelheim Pharmaceuticals
Structure		Download 2D MOL 3D MOL
Target and Pathway
Target(s)	Phosphodiesterase (PDE) 9	Target Info	Inhibitor	[551883]
KEGG Pathway	Purine metabolism
Pathway Interaction Database	Regulation of Androgen receptor activity
Reactome	cGMP effects
References
Ref 524914	ClinicalTrials.gov (NCT02240693) Alzheimer Disease Proof of Concept Study With BI 409306 Versus Placebo. U.S. National Institutes of Health.
Ref 551883	Clinical pipeline report, company report or official report of Boehringer Ingelheim pipeline.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.